A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models

Yu, Xufen; Li, Dongxu; Kottur, Jithesh; Shen, Yudao; Kim, Huen Suk; Park, Kwang-Su; Tsai, Yi-Hsuan; Gong, Weida; Wang, Jun; Suzuki, Kyogo; Parker, Joel; Herring, Laura; Kaniskan, H. Ümit; Cai, Ling; Jain, Rinku; Liu, Jing; Aggarwal, Aneel K.; Wang, Gang Greg; Jin, Jian

doi:10.1126/scitranslmed.abj1578

Title: A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models

Journal Article · Wed Sep 29 00:00:00 EDT 2021 · Science Translational Medicine

DOI:https://doi.org/10.1126/scitranslmed.abj1578· OSTI ID:1837161

^[1];

^[2];

^[1]; Shen, Yudao ^[1];

^[1];

^[2]; Gong, Weida ^[2]; Wang, Jun ^[2]; Suzuki, Kyogo ^[2];

^[2];

^[1]; Cai, Ling ^[2]; Jain, Rinku ^[1];

^[1];

^[2];

^[1]

Icahn School of Medicine at Mount Sinai, New York, NY (United States)
Univ. of North Carolina, Chapel Hill, NC (United States)

Interactions between WD40 repeat domain protein 5 (WDR5) and its various partners such as mixed lineage leukemia (MLL) and c-MYC are essential for sustaining oncogenesis in human cancers. However, inhibitors that block protein-protein interactions (PPIs) between WDR5 and its binding partners exhibit modest cancer cell killing effects and lack in vivo efficacy. Here, we present pharmacological degradation of WDR5 as a promising therapeutic strategy for treating WDR5-dependent tumors and report two high-resolution crystal structures of WDR5-degrader-E3 ligase ternary complexes. We identified an effective WDR5 degrader via structure-based design and demonstrated its in vitro and in vivo antitumor activities. On the basis of the crystal structure of an initial WDR5 degrader in complex with WDR5 and the E3 ligase von Hippel–Lindau (VHL), we designed a WDR5 degrader, MS67, and demonstrated the high cooperativity of MS67 binding to WDR5 and VHL by another ternary complex structure and biophysical characterization. MS67 potently and selectively depleted WDR5 and was more effective than WDR5 PPI inhibitors in suppressing transcription of WDR5-regulated genes, decreasing the chromatin-bound fraction of MLL complex components and c-MYC, and inhibiting the proliferation of cancer cells. In addition, MS67 suppressed malignant growth of MLL-rearranged acute myeloid leukemia patient cells in vitro and in vivo and was well tolerated in vivo. Collectively, our results demonstrate that structure-based design can be an effective strategy to identify highly active degraders and suggest that pharmacological degradation of WDR5 might be a promising treatment for WDR5-dependent cancers.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Brookhaven National Lab. (BNL), Upton, NY (United States)

Sponsoring Organization:: USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities Division

Grant/Contract Number:: SC0012704

OSTI ID:: 1837161

Report Number(s):: BNL-222545-2021-JACI

Journal Information:: Science Translational Medicine, Vol. 13, Issue 613; ISSN 1946-6234

Publisher:: AAASCopyright Statement

Country of Publication:: United States

Language:: English

References (79)

COMPASS: A complex of proteins associated with a trithorax-related SET domain protein Miller, T.; Krogan, N. J.; Dover, J. Proceedings of the National Academy of Sciences, Vol. 98, Issue 23 https://doi.org/10.1073/pnas.231473398	journal	October 2001
The Saccharomyces cerevisiae Set1 complex includes an Ash2 homologue and methylates histone 3 lysine 4 Roguev, A. The EMBO Journal, Vol. 20, Issue 24 https://doi.org/10.1093/emboj/20.24.7137	journal	December 2001
WDR5, a complexed protein Trievel, Raymond C.; Shilatifard, Ali Nature Structural & Molecular Biology, Vol. 16, Issue 7 https://doi.org/10.1038/nsmb0709-678	journal	July 2009
WD40 repeat domain proteins: a novel target class? Schapira, Matthieu; Tyers, Mike; Torrent, Maricel Nature Reviews Drug Discovery, Vol. 16, Issue 11 https://doi.org/10.1038/nrd.2017.179	journal	October 2017
Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide Patel, Anamika; Dharmarajan, Venkatasubramanian; Cosgrove, Michael S. Journal of Biological Chemistry, Vol. 283, Issue 47 https://doi.org/10.1074/jbc.C800164200	journal	October 2008
A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex Patel, Anamika; Vought, Valarie E.; Dharmarajan, Venkatasubramanian Journal of Biological Chemistry, Vol. 283, Issue 47 https://doi.org/10.1074/jbc.M806317200	journal	October 2008
Structural Basis for WDR5 Interaction (Win) Motif Recognition in Human SET1 Family Histone Methyltransferases Dharmarajan, Venkatasubramanian; Lee, Jeong-Heon; Patel, Anamika Journal of Biological Chemistry, Vol. 287, Issue 33 https://doi.org/10.1074/jbc.M112.364125	journal	June 2012
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer Carugo, Alessandro; Genovese, Giannicola; Seth, Sahil Cell Reports, Vol. 16, Issue 1 https://doi.org/10.1016/j.celrep.2016.05.063	journal	June 2016
WDR5 Expression Is Prognostic of Breast Cancer Outcome Dai, Xiaofeng; Guo, Wenwen; Zhan, Chunjun PLOS ONE, Vol. 10, Issue 9 https://doi.org/10.1371/journal.pone.0124964	journal	September 2015
Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation Chen, Xu; Xie, Weibin; Gu, Peng Scientific Reports, Vol. 5, Issue 1 https://doi.org/10.1038/srep08293	journal	February 2015
PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407 Tan, Xin; Chen, Shuai; Wu, Jiangxue Cell Death & Disease, Vol. 8, Issue 3 https://doi.org/10.1038/cddis.2017.111	journal	March 2017
TWIST1-WDR5- Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis Malek, Reem; Gajula, Rajendra P.; Williams, Russell D. Cancer Research, Vol. 77, Issue 12 https://doi.org/10.1158/0008-5472.CAN-16-2797	journal	May 2017
Up‐regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression Sun, Wei; Guo, Fuchao; Liu, Mingkai Journal of Cellular Biochemistry, Vol. 119, Issue 4 https://doi.org/10.1002/jcb.26491	journal	December 2017
Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma Wu, Yaping; Diao, Pengfei; Li, Zhongwu Journal of Oral Pathology & Medicine, Vol. 47, Issue 5 https://doi.org/10.1111/jop.12708	journal	April 2018
WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma Sun, Yuting; Bell, Jessica L.; Carter, Daniel Cancer Research, Vol. 75, Issue 23 https://doi.org/10.1158/0008-5472.CAN-15-0423	journal	October 2015
Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance Thomas, Lance R.; Adams, Clare M.; Wang, Jing Proceedings of the National Academy of Sciences, Vol. 116, Issue 50 https://doi.org/10.1073/pnas.1910391116	journal	November 2019
Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC Thomas, Lance R.; Wang, Qingguo; Grieb, Brian C. Molecular Cell, Vol. 58, Issue 3 https://doi.org/10.1016/j.molcel.2015.02.028	journal	May 2015
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5 Senisterra, Guillermo; Wu, Hong; Allali-Hassani, Abdellah Biochemical Journal, Vol. 449, Issue 1 https://doi.org/10.1042/BJ20121280	journal	December 2012
Synthesis, Optimization, and Evaluation of Novel Small Molecules as Antagonists of WDR5-MLL Interaction Bolshan, Yuri; Getlik, Matthäus; Kuznetsova, Ekaterina ACS Medicinal Chemistry Letters, Vol. 4, Issue 3 https://doi.org/10.1021/ml300467n	journal	February 2013
High-Affinity, Small-Molecule Peptidomimetic Inhibitors of MLL1/WDR5 Protein–Protein Interaction Karatas, Hacer; Townsend, Elizabeth C.; Cao, Fang Journal of the American Chemical Society, Vol. 135, Issue 2 https://doi.org/10.1021/ja306028q	journal	December 2012
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia Cao, Fang; Townsend, Elizabeth C.; Karatas, Hacer Molecular Cell, Vol. 53, Issue 2 https://doi.org/10.1016/j.molcel.2013.12.001	journal	January 2014
Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia Grebien, Florian; Vedadi, Masoud; Getlik, Matthäus Nature Chemical Biology, Vol. 11, Issue 8 https://doi.org/10.1038/nchembio.1859	journal	July 2015
Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth Zhu, Jiajun; Sammons, Morgan A.; Donahue, Greg Nature, Vol. 525, Issue 7568 https://doi.org/10.1038/nature15251	journal	September 2015
Structure-Based Optimization of a Small Molecule Antagonist of the Interaction Between WD Repeat-Containing Protein 5 (WDR5) and Mixed-Lineage Leukemia 1 (MLL1) Getlik, Matthäus; Smil, David; Zepeda-Velázquez, Carlos Journal of Medicinal Chemistry, Vol. 59, Issue 6 https://doi.org/10.1021/acs.jmedchem.5b01630	journal	March 2016
High-affinity small molecular blockers of mixed lineage leukemia 1 (MLL1)-WDR5 interaction inhibit MLL1 complex H3K4 methyltransferase activity Li, Dong-Dong; Chen, Wei-Lin; Wang, Zhi-Hui European Journal of Medicinal Chemistry, Vol. 124 https://doi.org/10.1016/j.ejmech.2016.08.036	journal	November 2016
Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)–Mixed Lineage Leukemia (MLL) Protein–Protein Interaction Karatas, Hacer; Li, Yangbing; Liu, Liu Journal of Medicinal Chemistry, Vol. 60, Issue 12 https://doi.org/10.1021/acs.jmedchem.6b01796	journal	June 2017
Discovery of Potent 2-Aryl-6,7-dihydro-5 H -pyrrolo[1,2- a ]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design Wang, Feng; Jeon, Kyu Ok; Salovich, James M. Journal of Medicinal Chemistry, Vol. 61, Issue 13 https://doi.org/10.1021/acs.jmedchem.8b00375	journal	June 2018
Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity Aho, Erin R.; Wang, Jing; Gogliotti, Rocco D. Cell Reports, Vol. 26, Issue 11 https://doi.org/10.1016/j.celrep.2019.02.047	journal	March 2019
Discovery and Optimization of Salicylic Acid-Derived Sulfonamide Inhibitors of the WD Repeat-Containing Protein 5–MYC Protein–Protein Interaction Macdonald, Jonathan D.; Chacón Simon, Selena; Han, Changho Journal of Medicinal Chemistry, Vol. 62, Issue 24 https://doi.org/10.1021/acs.jmedchem.9b01411	journal	November 2019
Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core Tian, Jianhua; Teuscher, Kevin B.; Aho, Erin R. Journal of Medicinal Chemistry, Vol. 63, Issue 2 https://doi.org/10.1021/acs.jmedchem.9b01608	journal	December 2019
Discovery of WD Repeat-Containing Protein 5 (WDR5)–MYC Inhibitors Using Fragment-Based Methods and Structure-Based Design Chacón Simon, Selena; Wang, Feng; Thomas, Lance R. Journal of Medicinal Chemistry, Vol. 63, Issue 8 https://doi.org/10.1021/acs.jmedchem.0c00224	journal	March 2020
Induced protein degradation: an emerging drug discovery paradigm Lai, Ashton C.; Crews, Craig M. Nature Reviews Drug Discovery, Vol. 16, Issue 2 https://doi.org/10.1038/nrd.2016.211	journal	November 2016
Targeted protein degradation: expanding the toolbox Schapira, Matthieu; Calabrese, Matthew F.; Bullock, Alex N. Nature Reviews Drug Discovery, Vol. 18, Issue 12 https://doi.org/10.1038/s41573-019-0047-y	journal	October 2019
Advancing targeted protein degradation for cancer therapy Dale, Brandon; Cheng, Meng; Park, Kwang-Su Nature Reviews Cancer, Vol. 21, Issue 10 https://doi.org/10.1038/s41568-021-00365-x	journal	June 2021
Catalytic in vivo protein knockdown by small-molecule PROTACs Bondeson, Daniel P.; Mares, Alina; Smith, Ian E. D. Nature Chemical Biology, Vol. 11, Issue 8 https://doi.org/10.1038/nchembio.1858	journal	June 2015
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins Buckley, Dennis L.; Raina, Kanak; Darricarrere, Nicole ACS Chemical Biology, Vol. 10, Issue 8 https://doi.org/10.1021/acschembio.5b00442	journal	June 2015
Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer Han, Xin; Wang, Chao; Qin, Chong Journal of Medicinal Chemistry, Vol. 62, Issue 2 https://doi.org/10.1021/acs.jmedchem.8b01631	journal	January 2019
3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation Testa, Andrea; Lucas, Xavier; Castro, Guilherme V. Journal of the American Chemical Society, Vol. 140, Issue 29 https://doi.org/10.1021/jacs.8b05807	journal	June 2018
Structural basis of PROTAC cooperative recognition for selective protein degradation Gadd, Morgan S.; Testa, Andrea; Lucas, Xavier Nature Chemical Biology, Vol. 13, Issue 5 https://doi.org/10.1038/nchembio.2329	journal	March 2017
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer Raina, Kanak; Lu, Jing; Qian, Yimin Proceedings of the National Academy of Sciences, Vol. 113, Issue 26 https://doi.org/10.1073/pnas.1521738113	journal	June 2016
Moonlighting with WDR5: A Cellular Multitasker Guarnaccia, Alissa; Tansey, William Journal of Clinical Medicine, Vol. 7, Issue 2 https://doi.org/10.3390/jcm7020021	journal	January 2018
Plasticity in binding confers selectivity in ligand-induced protein degradation Nowak, Radosław P.; DeAngelo, Stephen L.; Buckley, Dennis Nature Chemical Biology, Vol. 14, Issue 7 https://doi.org/10.1038/s41589-018-0055-y	journal	June 2018
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design Farnaby, William; Koegl, Manfred; Roy, Michael J. Nature Chemical Biology, Vol. 15, Issue 7 https://doi.org/10.1038/s41589-019-0294-6	journal	June 2019
Structure‐Based Design of a Macrocyclic PROTAC Testa, Andrea; Hughes, Scott J.; Lucas, Xavier Angewandte Chemie International Edition, Vol. 59, Issue 4 https://doi.org/10.1002/anie.201914396	journal	December 2019
Structural Insights into PROTAC-Mediated Degradation of Bcl-xL Chung, Chun-wa; Dai, Han; Fernandez, Esther ACS Chemical Biology, Vol. 15, Issue 9 https://doi.org/10.1021/acschembio.0c00266	journal	July 2020
Snapshots and ensembles of BTK and cIAP1 protein degrader ternary complexes Schiemer, James; Horst, Reto; Meng, Yilin Nature Chemical Biology, Vol. 17, Issue 2 https://doi.org/10.1038/s41589-020-00686-2	journal	November 2020
Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders Cheng, Meng; Yu, Xufen; Lu, Kaylene Journal of Medicinal Chemistry, Vol. 63, Issue 3 https://doi.org/10.1021/acs.jmedchem.9b01566	journal	January 2020
Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus Wang, Gang G.; Pasillas, Martina P.; Kamps, Mark P. Blood, Vol. 106, Issue 1 https://doi.org/10.1182/blood-2004-12-4664	journal	July 2005
NUP98–NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis Wang, Gang G.; Cai, Ling; Pasillas, Martina P. Nature Cell Biology, Vol. 9, Issue 7 https://doi.org/10.1038/ncb1608	journal	June 2007
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia Xu, Bowen; On, Doan M.; Ma, Anqi Blood, Vol. 125, Issue 2 https://doi.org/10.1182/blood-2014-06-581082	journal	January 2015
Genome engineering using the CRISPR-Cas9 system Ran, F. Ann; Hsu, Patrick D.; Wright, Jason Nature Protocols, Vol. 8, Issue 11 https://doi.org/10.1038/nprot.2013.143	journal	October 2013
Improved vectors and genome-wide libraries for CRISPR screening Sanjana, Neville E.; Shalem, Ophir; Zhang, Feng Nature Methods, Vol. 11, Issue 8 https://doi.org/10.1038/nmeth.3047	journal	July 2014
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells Shalem, Ophir; Sanjana, Neville E.; Hartenian, Ella Science, Vol. 343, Issue 6166, p. 84-87 https://doi.org/10.1126/science.1247005	journal	December 2013
iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4 https://doi.org/10.1107/S0907444910048675	journal	March 2011
Scaling and assessment of data quality Evans, Philip Acta Crystallographica Section D Biological Crystallography, Vol. 62, Issue 1, p. 72-82 https://doi.org/10.1107/S0907444905036693	journal	December 2005
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function Stebbins, Charles E.; Kaelin, William G.; Pavletich, Nikola P. Science, Vol. 284, Issue 5413 https://doi.org/10.1126/science.284.5413.455	journal	April 1999
Structural basis for molecular recognition and presentation of histone H3 By WDR5 Schuetz, Anja; Allali-Hassani, Abdellah; Martín, Fernando The EMBO Journal, Vol. 25, Issue 18 https://doi.org/10.1038/sj.emboj.7601316	journal	August 2006
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Integrating macromolecular X-ray diffraction data with the graphical user interface iMosflm Powell, Harold R.; Battye, T. Geoff G.; Kontogiannis, Luke Nature Protocols, Vol. 12, Issue 7 https://doi.org/10.1038/nprot.2017.037	journal	June 2017
PRODRG : a tool for high-throughput crystallography of protein–ligand complexes Schüttelkopf, Alexander W.; van Aalten, Daan M. F. Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 8 https://doi.org/10.1107/S0907444904011679	journal	July 2004
Single-vector inducible lentiviral RNAi system for oncology target validation Wiederschain, Dmitri; Susan, Wee; Chen, Lin Cell Cycle, Vol. 8, Issue 3 https://doi.org/10.4161/cc.8.3.7701	journal	February 2009
An H3K36 Methylation-Engaging Tudor Motif of Polycomb-like Proteins Mediates PRC2 Complex Targeting Cai, Ling; Rothbart, Scott B.; Lu, Rui Molecular Cell, Vol. 49, Issue 3 https://doi.org/10.1016/j.molcel.2012.11.026	journal	February 2013
Physical Association and Coordinate Function of the H3 K4 Methyltransferase MLL1 and the H4 K16 Acetyltransferase MOF Dou, Yali; Milne, Thomas A.; Tackett, Alan J. Cell, Vol. 121, Issue 6 https://doi.org/10.1016/j.cell.2005.04.031	journal	June 2005
Epigenetic Perturbations by Arg882-Mutated DNMT3A Potentiate Aberrant Stem Cell Gene-Expression Program and Acute Leukemia Development Lu, Rui; Wang, Ping; Parton, Trevor Cancer Cell, Vol. 30, Issue 1 https://doi.org/10.1016/j.ccell.2016.05.008	journal	July 2016
An Alternative Approach to ChIP-Seq Normalization Enables Detection of Genome-Wide Changes in Histone H3 Lysine 27 Trimethylation upon EZH2 Inhibition Egan, Brian; Yuan, Chih-Chi; Craske, Madeleine Lisa PLOS ONE, Vol. 11, Issue 11 https://doi.org/10.1371/journal.pone.0166438	journal	November 2016
Fast and accurate long-read alignment with Burrows–Wheeler transform Li, Heng; Durbin, Richard Bioinformatics, Vol. 26, Issue 5 https://doi.org/10.1093/bioinformatics/btp698	journal	January 2010
Model-based Analysis of ChIP-Seq (MACS) Zhang, Yong; Liu, Tao; Meyer, Clifford A. Genome Biology, Vol. 9, Issue 9 https://doi.org/10.1186/gb-2008-9-9-r137	journal	January 2008
A User's Guide to the Encyclopedia of DNA Elements (ENCODE) PLoS Biology, Vol. 9, Issue 4 https://doi.org/10.1371/journal.pbio.1001046	journal	April 2011
BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis Fan, Huitao; Lu, Jiuwei; Guo, Yiran Nature Genetics, Vol. 52, Issue 12 https://doi.org/10.1038/s41588-020-00729-3	journal	November 2020
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation Ren, Zhihong; Ahn, Jeong Hyun; Liu, Hequn Blood, Vol. 134, Issue 14 https://doi.org/10.1182/blood.2019000578	journal	August 2019
ZFX Mediates Non-canonical Oncogenic Functions of the Androgen Receptor Splice Variant 7 in Castrate-Resistant Prostate Cancer Cai, Ling; Tsai, Yi-Hsuan; Wang, Ping Molecular Cell, Vol. 72, Issue 2 https://doi.org/10.1016/j.molcel.2018.08.029	journal	October 2018
MapSplice: Accurate mapping of RNA-seq reads for splice junction discovery Wang, Kai; Singh, Darshan; Zeng, Zheng Nucleic Acids Research, Vol. 38, Issue 18 https://doi.org/10.1093/nar/gkq622	journal	August 2010
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome Li, Bo; Dewey, Colin N. BMC Bioinformatics, Vol. 12, Issue 1 https://doi.org/10.1186/1471-2105-12-323	journal	August 2011
Differential expression analysis for sequence count data Anders, Simon; Huber, Wolfgang Genome Biology, Vol. 11, Issue 10 https://doi.org/10.1186/gb-2010-11-10-r106	journal	October 2010
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Subramanian, A.; Tamayo, P.; Mootha, V. K. Proceedings of the National Academy of Sciences, Vol. 102, Issue 43, p. 15545-15550 https://doi.org/10.1073/pnas.0506580102	journal	September 2005
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice Townsend, Elizabeth C.; Murakami, Mark A.; Christodoulou, Alexandra Cancer Cell, Vol. 29, Issue 4 https://doi.org/10.1016/j.ccell.2016.03.008	journal	April 2016
Genomic impact of transient low-dose decitabine treatment on primary AML cells Klco, Jeffery M.; Spencer, David H.; Lamprecht, Tamara L. Blood, Vol. 121, Issue 9 https://doi.org/10.1182/blood-2012-09-459313	journal	February 2013

Similar Records

Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core

Journal Article · Fri Dec 20 00:00:00 EST 2019 · Journal of Medicinal Chemistry · OSTI ID:1837161

Tian, Jianhua; Teuscher, Kevin B.; Aho, Erin R.; +22 more

Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC)

Journal Article · Mon Oct 15 00:00:00 EDT 2018 · Biochemical and Biophysical Research Communications · OSTI ID:1837161

Kang, Chung Hyo; Lee, Dong Ho; Lee, Chong Ock; +1 more

Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein

Journal Article · Sun Sep 01 00:00:00 EDT 2013 · Toxicology and Applied Pharmacology · OSTI ID:1837161

Song, Xiuming; Yao, Jing; Wang, Fei; +8 more

Related Subjects

99 GENERAL AND MISCELLANEOUS

Title: A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models

Citation Formats

References (79)

Similar Records

Related Subjects